APS 2019 attendees posted using #APS2019 208 times, earning 441,923 impressions at the Scientific Meeting. Thanks to you and the 2019 Social Media Champions, Twitter was a forum for the new pain science and treatments discussed at the meeting.
The 2nd Women in Leadership Panel at the APS Scientific Meeting in Milwaukee
APS Treasurer and organizer of the Women in Leadership Panel, Tonya Palermo, PhD, reflects on this year’s event in Milwaukee.
The Role of Nonpharmacological Approaches to Pain Management: Proceedings of a Workshop
New publication highlighting presentations on the effectiveness of nonpharmacological treatments and integrative health models for pain management.
Acupuncture in the ED a Feasible, Beneficial Non-Opioid Option for Pain
New research suggests that acupuncture is a feasible and beneficial nonpharmacologic option for treating pain in the emergency department.
Cannabis Plus Opioids in Chronic Pain: Not a Great Combo
Andrew Rogers reports on anxiety and depression in patients using both prescription opioids and recreational marijuana.
Novel, ‘Non-habit Forming’ Medication May Reduce Low Back Pain
New research suggests effectiveness of “non-habit-forming” neurosteroid in the treatment of chronic lower back pain.
FDA’s Center for Drug Evaluation and Research Releases Statement on New Opioid Analgesic Labeling Changes
Douglas Throckmorton, M.D., releases statement on behalf of FDA addressing changes to new opioid analgesic labeling.
Perceived Distractions May Contribute to ‘Fibro Fog’
APS member Anna Kratz, PhD reports on the relationship between distraction and cognitive dysfunction in fibromyalgia patients at the 2019 Scientific Meeting.
Can Blocking Kappa Receptors Reduce Opioid Dependency?
APS member Jose Morón-Concepcion, PhD reports on the effects of blocking kappa opioid receptors at the 2019 Scientific Meeting.
Escalating Opioid Doses in Chronic Pain
Benjamin Morasco, PhD, reports on outcomes of long-term opioid use at the 2019 Scientific Meeting.
Pain Persistent after Sexual Assault
APS member Samuel McLean, MD, MPH, reports on persistent pain in cases of sexual abuse at the 2019 Scientific Meeting.
Opioid Stigma and Cancer
Haily Bulls, PhD, reports on opioid stigma in cancer patients at the 2019 Scientific Meeting.
News Release: Dr. Langevin’s Plenary Talk at the 2019 Scientific Meeting
Dr. Langevin presents “Put the Brain and Body Back Together in Pain Research” at the 2019 Scientific Meeting.
News Release: Dr. Koroshetz’s Plenary Talk at the 2019 Scientific Meeting
Dr. Koroshetz presents “NIH Calling Pain Investigators to Join HEAL Initiative Research” at the 2019 Scientific Meeting.
News Release: Dr. Moron-Concepcion’s Plenary Talk at the 2019 Scientific Meeting
Dr. Moron-Concepcion presents “Targeting Emotional Aspects of Pain Could Reduce Opioid Dependency” at the 2019 Scientific Meeting.
Women’s Pain is Different From Men’s – The Drugs Could Be Too
Dr. Price, APS Board member, and Dr. Mogil, Narcessian award recipient, discuss differences in biological pain pathways between men and women and the pain-relieving drugs used to treat them.
Progress Against Cancer Pain Taking Many Directions, NCI Reports
Dr. Maixner, APS President, discusses advances in understanding underlying pain mechanisms with Oncology Times.
AMERSA Conference Call for Abstracts and Workshops
The Association for Multidisciplinary Education and Research in Substance use and Addiction is an interdisciplinary organization that holds a conference every November, and is holding this year’s conference in Boston on November 7-9th.
Distinguished Physician and Scientist Dr. Gavril Pasternak Has Passed Away
Dr. Pasternak was an APS member for over two decades, a frequent attendee and esteemed speaker at APS Scientific Meetings, and most recently was awarded the 2019 Frederick W.L. Kerr Basic Science Research Award for his excellence and achievement in pain scholarship.
